160 related articles for article (PubMed ID: 3137275)
21. IRG1 and Inducible Nitric Oxide Synthase Act Redundantly with Other Interferon-Gamma-Induced Factors To Restrict Intracellular Replication of Legionella pneumophila.
Price JV; Russo D; Ji DX; Chavez RA; DiPeso L; Lee AY; Coers J; Vance RE
mBio; 2019 Nov; 10(6):. PubMed ID: 31719183
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Legionella pneumophila lung abscess with clindamycin.
Buggy BP; Saravolatz LD
Clin Infect Dis; 1995 May; 20(5):1158-62. PubMed ID: 7619992
[TBL] [Abstract][Full Text] [Related]
23. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
Barker JE; Farrell ID
J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
[TBL] [Abstract][Full Text] [Related]
24. Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.
Havlichek D; Saravolatz L; Pohlod D
Antimicrob Agents Chemother; 1987 Oct; 31(10):1529-34. PubMed ID: 3435101
[TBL] [Abstract][Full Text] [Related]
25. Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes.
Horwitz MA
J Exp Med; 1987 Nov; 166(5):1310-28. PubMed ID: 3681188
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
[TBL] [Abstract][Full Text] [Related]
28. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
29. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway.
Schiavoni G; Mauri C; Carlei D; Belardelli F; Pastoris MC; Proietti E
J Immunol; 2004 Jul; 173(2):1266-75. PubMed ID: 15240719
[TBL] [Abstract][Full Text] [Related]
30. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.
Skerrett SJ; Martin TR
Infect Immun; 1996 Aug; 64(8):3236-43. PubMed ID: 8757859
[TBL] [Abstract][Full Text] [Related]
31. The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol.
Fitzgeorge RB
J Infect; 1985 May; 10(3):189-93. PubMed ID: 3161953
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Baltch AL; Smith RP; Franke MA; Michelsen PB
Antimicrob Agents Chemother; 1998 Dec; 42(12):3153-6. PubMed ID: 9835507
[TBL] [Abstract][Full Text] [Related]
33. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Sep; 66(3):441-50. PubMed ID: 7190579
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
[TBL] [Abstract][Full Text] [Related]
35. Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts.
Deng JC; Tateda K; Zeng X; Standiford TJ
Infect Immun; 2001 Oct; 69(10):6382-90. PubMed ID: 11553582
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immunity in Legionnaires' disease.
Horwitz MA
J Clin Invest; 1983 Jun; 71(6):1686-97. PubMed ID: 6345589
[TBL] [Abstract][Full Text] [Related]
37. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
Edelstein PH; Hu B; Edelstein MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
[TBL] [Abstract][Full Text] [Related]
39. KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of
Brunel R; Descours G; Durieux I; Doublet P; Jarraud S; Charpentier X
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158279
[No Abstract] [Full Text] [Related]
40. Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice.
Salins S; Newton C; Widen R; Klein TW; Friedman H
Infect Immun; 2001 Jun; 69(6):3605-10. PubMed ID: 11349020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
